Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Inclusion Criteria:

- Healthy male or female adults aged between 19 to 64 years, inclusive for the primary
cohort), or aged 65 years or older (for the exploratory cohort), at the time of
vaccination.

Exclusion Criteria:

- Administration of an influenza vaccine within six months prior to study entry

- Administration of a diphtheria-tetanus (Td) booster within the previous 5 years.

- Administration of a Tdap vaccine at any time prior to study entry.

- Administration of any investigational or non-registered drug or vaccine other than the
study vaccines within 30 days preceding vaccination, or planned use during the entire
study period.

- History of diphtheria and/or tetanus and/or pertussis disease.

- History of serious allergic reaction (e.g. anaphylaxis) following any other tetanus
toxoid, diphtheria toxoid or pertussis-containing vaccine or influenza vaccine or any
component of the study vaccines.